Literature DB >> 20705505

Genotypic variation of Pneumocystis jirovecii isolates in India based on sequence diversity at mitochondrial large subunit rRNA.

Rashmi Gupta1, Bijay Ranjan Mirdha, Randeep Guleria, Sanjay Kumar Agarwal, Jyotish Chandra Samantaray, Lalit Kumar, Sushil Kumar Kabra, Kalpana Luthra, Vishnubhatla Sreenivas, Venkateswaran K Iyer.   

Abstract

Pneumocystis pneumonia (PCP), a common and serious opportunistic infection in immunocompromised patients, is caused by Pneumocystis jirovecii (formerly known as Pneumocystis carinii f. sp. hominis). The aim of the present study was to describe the prevalence and distribution of genotypes of P. jirovecii based on sequence polymorphisms at mitochondrial large subunit ribosomal RNA (mt LSU rRNA) region in both HIV and non-HIV immunocompromised individuals with a positive PCR result for PCP in a tertiary health care centre in northern India. From January 2005 to October 2008, 50 patients [22 HIV-seropositive individuals, 10 post-renal transplant (PRT) recipients, 3 cancer patients, and 15 patients with various other kinds of immunosuppression] were found to be positive for P. jirovecii using PCR at the mt LSU rRNA gene. Genotyping of the positive samples was performed at the mt LSU rRNA locus. Genotype 2 was the most common accounting for 42% of total types. This was followed by the genotypes 3 (24%), 1 (20%), and 4 (8%). Mixed infection was observed in 3 cases (6%). The rates of genotype distribution were similar in HIV-seropositive individuals, cancer patients, and in patients with other kinds of immunosuppression. In the PRT recipients, genotype 1 was the most prevalent type (80%). This is the first study describing the prevalence of genotypes in HIV-infected and HIV-uninfected, immunocompromised patients based on the mt LSU rRNA gene from the Indian subcontinent. The most prevalent genotype observed was type 2 in contrast to many studies from other parts of the world where genotype 1 was the most prevalent type, suggesting geographical variation.
Copyright © 2010 Elsevier GmbH. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20705505     DOI: 10.1016/j.ijmm.2010.05.001

Source DB:  PubMed          Journal:  Int J Med Microbiol        ISSN: 1438-4221            Impact factor:   3.473


  5 in total

1.  Circulating genotypes of Pneumocystis jirovecii and its clinical correlation in patients from a single tertiary center in India.

Authors:  Y Singh; B R Mirdha; R Guleria; S Khalil; A Panda; R Chaudhry; A Mohan; S K Kabra; L Kumar; S K Agarwal
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2017-04-11       Impact factor: 3.267

2.  Prevalence and genotype distribution of Pneumocystis jirovecii in Cuban infants and toddlers with whooping cough.

Authors:  Ernesto X Monroy-Vaca; Yaxsier de Armas; María T Illnait-Zaragozí; Gilda Toraño; Raúl Diaz; Dania Vega; Ileana Alvarez-Lam; Enrique J Calderón; Christen R Stensvold
Journal:  J Clin Microbiol       Date:  2013-10-16       Impact factor: 5.948

3.  Clinical characteristics of hospital-onset Pneumocystis pneumonia and genotypes of Pneumocystis jirovecii in a single tertiary centre in Korea.

Authors:  Tark Kim; Sang-Oh Lee; Hyo-Lim Hong; Ju Young Lee; Sung-Han Kim; Sang-Ho Choi; Mi-Na Kim; Yang Soo Kim; Jun Hee Woo; Heungsup Sung
Journal:  BMC Infect Dis       Date:  2015-02-26       Impact factor: 3.090

4.  Molecular diagnosis and genotyping of Pneumocystis jirovecii in bronchoalveolar lavage samples obtained from patients with pulmonary disorder.

Authors:  Abdolmajid Fata; Bahareh Abdollahi; Fariba Rezaeetalab; Davood Attaran; Mohsen Najjari; Mohammad J Najafzadeh
Journal:  Curr Med Mycol       Date:  2019-09

5.  Multilocus Genotyping of Pneumocystis jirovecii from Deceased Cuban AIDS Patients Using Formalin-Fixed and Paraffin-Embedded Tissues.

Authors:  Vicente Friaza; Yaxsier de Armas; Virginia Capó; Rubén Morilla; Arturo Plascencia-Hernández; Héctor R Pérez-Gómez; Enrique Iglesias; Luis Fonte; Carmen de la Horra; Enrique J Calderón
Journal:  J Fungi (Basel)       Date:  2021-12-05
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.